FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides compounds of general formula I: (I), in which R is methyl or phenyl and n=0 or 1, as vasodilator, hypotensive, spasmolytic, antianginal agents and blood platelet aggregation inhibitors, activities of which are determined by their activating soluble form of guanylate-cyclase. EFFECT: enlarged assortment of drugs. 3 cl, 4 dwg, 4 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
SPECIFIC REGULATOR OF ACTIVITY OF NUCLEOTIDE-DEPENDENT ENZYMES | 1997 |
|
RU2130490C1 |
INCLUSION COMPLEXES OF DERIVATIVES OF 1,2,5-OXA- -DIAZOLE-2-OXIDE WITH POLYCYCLIC DERIVATIVES OF GLUCOPYRANOSE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2186782C1 |
DERIVATIVES OF 1,4,2,5-DIOXADIAZINE | 2001 |
|
RU2212409C1 |
DONOR OF NITROGEN OXIDE ACTIVATING SOLUBLE FORM OF GUANYLATE CYCLASE, INHIBITING PLATELET AGGREGATION AND EXHIBITING SPASMOLYTIC AND VASODILATING EFFECT | 2001 |
|
RU2208438C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF SOLUBLE FORM OF GUANYLATE CYCLASE | 1998 |
|
RU2139932C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLASE | 2001 |
|
RU2189392C1 |
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2123046C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2188865C1 |
ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2122582C1 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1999 |
|
RU2151799C1 |
Authors
Dates
2001-04-20—Published
1997-12-26—Filed